ANI Pharmaceuticals Inc (ANIP)
68.04
+2.16
(+3.28%)
USD |
NASDAQ |
May 10, 16:00
68.04
0.00 (0.00%)
After-Hours: 19:10
ANI Pharmaceuticals Accounts Payable (Quarterly): 36.68M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 36.68M |
September 30, 2023 | 34.08M |
June 30, 2023 | 28.50M |
March 31, 2023 | 32.69M |
December 31, 2022 | 29.30M |
September 30, 2022 | 18.99M |
June 30, 2022 | 27.64M |
March 31, 2022 | 22.06M |
December 31, 2021 | 22.97M |
September 30, 2021 | 11.51M |
June 30, 2021 | 12.98M |
March 31, 2021 | 13.77M |
December 31, 2020 | 11.26M |
September 30, 2020 | 13.46M |
June 30, 2020 | 14.21M |
March 31, 2020 | 12.48M |
December 31, 2019 | 14.61M |
September 30, 2019 | 10.95M |
June 30, 2019 | 9.809M |
March 31, 2019 | 10.52M |
December 31, 2018 | 8.884M |
September 30, 2018 | 7.257M |
June 30, 2018 | 7.949M |
March 31, 2018 | 4.886M |
December 31, 2017 | 3.63M |
Date | Value |
---|---|
September 30, 2017 | 5.821M |
June 30, 2017 | 3.153M |
March 31, 2017 | 4.785M |
December 31, 2016 | 3.389M |
September 30, 2016 | 4.73M |
June 30, 2016 | 4.961M |
March 31, 2016 | 3.04M |
December 31, 2015 | 2.066M |
September 30, 2015 | 2.633M |
June 30, 2015 | 1.325M |
March 31, 2015 | 2.288M |
December 31, 2014 | 2.654M |
September 30, 2014 | 3.059M |
June 30, 2014 | 1.731M |
March 31, 2014 | 2.66M |
December 31, 2013 | 1.429M |
September 30, 2013 | 2.087M |
June 30, 2013 | 1.635M |
March 31, 2013 | 0.1644M |
December 31, 2012 | 1.129M |
September 30, 2012 | 2.005M |
June 30, 2012 | 3.836M |
March 31, 2012 | 3.282M |
December 31, 2011 | 3.151M |
September 30, 2011 | 6.042M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
9.809M
Minimum
Jun 2019
36.68M
Maximum
Dec 2023
19.89M
Average
14.61M
Median
Dec 2019
Accounts Payable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 1.893M |
ADMA Biologics Inc | 15.66M |
Moderna Inc | 183.00M |
Dentsply Sirona Inc | 279.00M |
Allogene Therapeutics Inc | 5.897M |